NeutriSci International Inc. Stock price

Equities

NU

CA64129Y1079

Food Processing

Delayed Toronto S.E. 12:00:00 2024-03-21 pm EDT 5-day change 1st Jan Change
0.005 CAD 0.00% Intraday chart for NeutriSci International Inc. 0.00% 0.00%
Sales 2021 80.89K 59.66K Sales 2022 458K 338K Capitalization 2.64M 1.95M
Net income 2021 -1M -738K Net income 2022 - 0 EV / Sales 2021 113 x
Net Debt 2021 29.29K 21.6K Net Debt 2022 3.36K 2.48K EV / Sales 2022 5.77 x
P/E ratio 2021
-5.55 x
P/E ratio 2022
-3.23 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 98.97%
More Fundamentals * Assessed data
Dynamic Chart
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NeutriSci International Inc. Announces Board of Director Changes CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NeutriSci International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NeutriSci International Inc. Provides Update to Product Arrangement with Gaia Grow Corp CI
NeutriSci International Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NeutriSci International Inc. Auditor Raises 'Going Concern' Doubt CI
NeutriSci International Inc. announced that it has received CAD 0.196774 million in funding CI
NeutriSci International Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
NeutriSci International Inc. announced that it expects to receive CAD 0.25 million in funding CI
NeutriSci International Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
NeutriSci Announces Distribution Start of neuenergy in Europe CI
NeutriSci Shipped Order to Tabletz Distribution Partner; Up 25.8% in Early Frankfurt Trading MT
NeutriSci International Inc. Ships Order to Tabletz Distribution Partner CI
NeutriSci International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 month
0.01
Extreme 0.005
0.01
Current year
0.01
Extreme 0.005
0.01
1 year
0.01
Extreme 0.005
0.02
3 years
0.01
Extreme 0.005
0.21
5 years
0.01
Extreme 0.005
0.35
10 years
0.01
Extreme 0.005
0.67
More quotes
Managers TitleAgeSince
Chief Executive Officer - 09-12-31
Director of Finance/CFO 62 -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 09-12-31
Director/Board Member - 14-11-25
More insiders
Date Price Change Volume
24-03-27 - -100.00% 800
24-03-21 0.005 +∞% 0

Delayed Quote Toronto S.E., March 21, 2024 at 12:00 pm EDT

More quotes
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.
More about the company
  1. Stock
  2. Equities
  3. Stock NeutriSci International Inc. - Toronto S.E.